Serial Review: The powerhouse takes control of the cell; the role of mitochondria in signal transduction
Mitochondrial dysfunction in cardiovascular disease

https://doi.org/10.1016/j.freeradbiomed.2005.02.014Get rights and content

Abstract

Whereas the pathogenesis of atherosclerosis has been intensively studied and described, the underlying events that initiate cardiovascular disease are not yet fully understood. A substantial number of studies suggest that altered levels of oxidative and nitrosoxidative stress within the cardiovascular environment are essential in the development of cardiovascular disease; however, the impact of such changes on the subcellular or organellar components and their functions that are relevant to cardiovascular disease inception are less understood. In this regard, studies are beginning to show that mitochondria not only appear susceptible to damage mediated by increased oxidative and nitrosoxidative stress, but also play significant roles in the regulation of cardiovascular cell function. In addition, accumulating evidence suggests that a common theme among cardiovascular disease development and cardiovascular disease risk factors is increased mitochondrial damage and dysfunction. This review discusses aspects relating mitochondrial damage and function to cardiovascular disease risk factors and disease development.

Introduction

With exception of the worldwide Spanish influenza epidemic of 1918, cardiovascular disease (CVD) has been the leading cause of mortality and morbidity in the United States every year since 1900 [1]. Atherosclerosis is the leading cause of CVD-related mortality, accounting for nearly three-fourths of all deaths from heart disease. Endothelial cell injury and inflammation are thought to be the first steps in the development of atherosclerosis, which can lead to the accumulation of lipids in injured areas of the artery. Increased adherence of monocytes/macrophages leads to the formation of lipid-engorged “foam cells,” which together with T lymphocytes, become “fatty streaks,” Fatty streaks can progress (via continued cell influx and proliferation) to an intermediate, atherosclerotic fibro-fatty lesion and ultimately to a fibrous plaque. Eventually, arterial wall thickening, plaque rupture, and occlusion lead to the clinical manifestations of CVD, myocardial ischemia, and infarction (heart attack) [2], [3], [4], [5], [6], [7]. Although CVD is typically considered to be an “adult” disease, the events that lead to atherosclerosis probably begin decades before the clinical manifestations of the disease become evident. Hence, atherosclerosis can be a slow, complex inflammatory disease that can start in childhood and progress with age. Although much is known about the progression and development of CVD, its specific underlying etiology remains elusive.

A plethora of studies have revealed that among the potential causes of CVD, free radical-mediated changes within the cardiovascular milieu are currently the most popular suspects [8], [9], [10], [11], [12]. The concept that oxidative stress is important in the pathogenesis of CVD was conceived from studies that noted the cytotoxic and atherogenic properties of oxidized LDL (oxLDL) cholesterol [13], [14], [15], [16], [17]. Subsequently, it has become apparent that native LDL cholesterol can be converted to oxLDL cholesterol via several pathways involving oxidative and/or nitrosoxidative stress [10]. An enormous amount of study and discovery has been made regarding the multiple potential sources of cellular oxidative and/or nitrosoxidative stress (e.g., NADPH oxidase, xanthine oxidase, myeloperoxidase, mitochondria, and iNOS) [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30], [31] (Fig. 1).

Whereas it is clear that proteins, membranes, lipids, and genetic materials are susceptible to damage mediated by oxidative and nitrosoxidative stress, it is not yet clear whether a “common” subcellular target exists which is vulnerable to free radical-mediated damage that will be relevant to CVD development. Subcellular components that play important roles in a variety of cell functions, including growth, death, signaling, and bioenergetics would appear to be important candidates in this regard.

Section snippets

Mitochondrial oxidative phosphorylation and mitochondrial DNA

Numerous reports have shown that mitochondria are sensitive to both reactive oxygen- and nitrogen species-mediated damage and alterations in function [25], [32], [33], [34], [35], [36], [37]. Because they are the major source of oxidative energy for the cell, mitochondria have been stereotyped as “cellular powerplants.” Mitochondrial oxidative phosphorylation (OXPHOS) consists of five multiple subunit enzyme complexes embedded within the mitochondrial inner membrane, which coordinately function

Mitochondrial DNA mutations and human disease

MtDNA mutations have been associated with a wide array of human diseases and can show marked clinical heterogeneity, including deficits in neuromuscular, musculoskeletal, cardiovascular, renal, endocrine, and neural function. Cardiac complications, particularly cardiac dysrhythmias and cardiomyopathy, are prominent features of many diseases associated with mtDNA mutations. Much of the clinical variability of diseases caused by specific mtDNA mutations appears to result from: (i) the severity of

Mitochondrial-derived oxidants

More recently, it has been noted that the mitochondrion also serves as a primary cellular source of endogenous oxidants. Whereas the majority of oxygen consumed by the mitochondrion is converted to water at complex IV (cytochrome c oxidase), oxygen can pick up electrons directly from the ubiquinone site in complex III and flavin mononucleotide group of complex I to generate O2radical dot [25], [58]. Recently, it has been shown that electrons derived from FADH2 (complex II substrate) can undergo “reverse

Regulation of mitochondrial oxidant production

A number of physiologic factors regulate mitochondrial oxidant generation, including local concentrations of both reactive nitrogen and oxygen species, mitochondrial antioxidants, electron transport efficiency, metabolic reducing equivalent availability (NADH and FADH2), uncoupling protein (UCP) activities, cytokines, and overall organelle integrity (damage to membranes, DNA, and proteins). radical dotLow radical dotNO concentrations can modulate mitochondrial respiration and oxygen consumption through reversible

Mitochondria are targets of ROS

Whereas ROS and RNS are capable of targeting a variety of subcellular components, the mitochondrial membranes, proteins, and mtDNA appear particularly sensitive to oxidative and nitrosative damage [33], [34], [37], [95], [96], [97]. Studies have shown that reactive species such as H2O2 and ONOO can induce a variety of effects, including preferential and sustained mtDNA damage, altered mitochondrial transcript levels and mitochondrial protein synthesis, and lowered mitochondrial redox

Mitochondrial damage/dysfunction is associated with CVD

Several lines of evidence suggest that an association exists among CVD development, mitochondrial damage, and function. It has been shown that CVD patients have increased mtDNA damage when compared with healthy controls in both the heart and the aorta [51], [53], [102], [111]. Atherosclerotic lesions in brain microvessels from Alzheimer's (AD) patients and rodent AD models have significantly more mtDNA deletions and abnormalities (as do the endothelium and perivascular cells), suggesting that

Conclusions

By virtue of their ability to modulate local subcellular oxidant levels through a complex interaction of respiratory regulation, coupling, antioxidant activity, and relative balance of ROS and RNS, mitochondria can play critical functions in cell signaling, growth, and death. Consequently, in some cell types, mitochondrial modulation of redox regulation (e.g., in response to radical dotNO and/or cytokines) may be the initial defect, not energy production. Hence, although it was originally thought that

Acknowledgments

This work was supported by NIH Grants ES 11172 and HL 77419.

References (218)

  • E. Arnaudo et al.

    Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy

    Lancet

    (1991)
  • Y. Zhang et al.

    The oxidative inactivation of mitochondrial electron transport chain components and ATPase

    J. Biol. Chem.

    (1990)
  • H.J. Forman et al.
  • H.J. Forman et al.

    Superoxide radical and hydrogen peroxide in mitochondria

  • K. Chen et al.

    c-Jun-N-terminal Kinase Activation by hydrogen peroxide in endothelial cells involves Src-dependent epidermal growth factor receptor transactivation

    J. Biol. Chem.

    (2001)
  • K.Z. Guyton et al.

    Activation of mitogen-activated protein kinase by by H2O2

    J. Biol. Chem.

    (1996)
  • C. Leeuwenburgh et al.

    Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima

    J. Biol. Chem.

    (1997)
  • H. Ischiropoulos

    Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species

    Arch. Biochem. Biophys.

    (1998)
  • W. Wu et al.

    Eosinophil peroxidase nitrates protein tyrosyl residues

    J. Biol. Chem.

    (1999)
  • C. van Dalen et al.

    Nitrite as a substrate and inhibitor of myeloperoxidase

    J. Biol. Chem.

    (2000)
  • L. Castro et al.

    Cytochrome c: a catalyst and target of nitrite-hydrogen peroxide-dependent protein nitration

    Arch. Biochem. Biophys.

    (2004)
  • A. Ramachandran et al.

    Mitochondria, nitric oxide, and cardiovascular dysfunction

    Free Radic. Biol. Med.

    (2002)
  • M. Jaburek et al.

    Transport function and regulation of mitochondrial uncoupling proteins 2 and 3

    J. Biol. Chem.

    (1999)
  • J.A. Stuart et al.

    Mitochondrial proton leak and the uncoupling protein 1 homologues

    Biochim. Biophys. Acta

    (2001)
  • D.A. Talbot et al.

    Production of endogenous matrix superoxide from mitochondrial complex I leads to activation of uncoupling protein 3

    FEBS Lett.

    (2004)
  • S.K. Manna

    Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1

    J. Biol. Chem.

    (1998)
  • K. Schulze-Osthoff et al.

    Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation

    J. Biol. Chem.

    (1992)
  • S.W. Ballinger et al.

    Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells

    Exp. Eye Res.

    (1999)
  • L.-J. Yan et al.

    Prevention of flight activity prolongs the life span of the housefly, Musca Domestica, and attenuates the age-associated oxidative damage to specific mitochondrial proteins

    Free Radic. Biol. Med.

    (2000)
  • L. Flohe et al.

    Superoxide dismutase assays

    Methods Enzymol.

    (1984)
  • A. Hausladen et al.

    Measuring nitric oxide and superoxide: rate constants for aconitase reactivity

    Methods Enzymol.

    (1996)
  • R. Ross

    The Pathogenesis of atherosclerosis: a perspective for the 1990s

    Nature

    (1993)
  • R. Ross

    Cell biololgy of atherosclerosis

    Annu. Rev. Physiol.

    (1995)
  • R. Ross

    Growth regulatory mechanisms and formation of the lesions of atherosclerosis

    Ann. N.Y. Acad. Sci.

    (1995)
  • R. Ross

    Mechanisms of disease: atherosclerosis—an inflammatory disease

    N. Engl. J. Med.

    (1999)
  • R.W. Alexander

    Hypertension and the pathogenesis of atherosclerosis: Oxidative stress and the mediation of arterial inflammatory response: a new perspective

    Hypertension

    (1995)
  • G. Rubanyi

    The role of endothelium in cardiovascular homeostasis and diseases

    J. Cardiovasc. Pharm.

    (1993)
  • B. Halliwell

    Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis

    Br. J. Exp. Pathol.

    (1989)
  • H. Massaeli et al.

    Involvement of lipoproteins, free radicals, and calcium in cardiovascular disease processes

    Cardiovasc. Res.

    (1995)
  • D. Steinberg et al.

    Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

    N. Engl. J. Med.

    (1989)
  • J.L. Witztum et al.

    Role of oxidized low density lipoprotein in atherogenesis

    J. Clin. Invest.

    (1991)
  • V. Reid et al.

    Cytotoxicity of oxidised low density lipoprotein to mouse peritoneal macrophages: an ultrastructural study

    J. Pathol.

    (1993)
  • J.A. Holland et al.

    Atherogenic levels of low-density lipoprotein increase hydrogen peroxide generation in cultured human endothelial cells: possible mechanism of heightened endocytosis

    J. Cell. Physiol.

    (1996)
  • Y. Ohara et al.

    Hypercholesterolemia increases endothelial superoxide anion production

    J. Clin. Invest.

    (1993)
  • S.A. Jones et al.

    Expression of phagocyte NADPH oxidase components in human endothelial cells

    Am. J. Physiol.

    (1996)
  • R.M. Touyz et al.

    Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II

    Circ. Res.

    (2002)
  • J.S. McNally et al.

    Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress

    Am. J. Physiol. Heart Circ. Physiol.

    (2003)
  • U. Landmesser et al.

    Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

    J. Clin. Invest.

    (2003)
  • S. Tan et al.

    Circulating xanthoine oxidase in human ischemia reperfusion

    South Med. J.

    (1995)
  • Cited by (351)

    View all citing articles on Scopus

    This article is part of a series of reviews on “The Powerhouse Takes Control of the Cell: the Role of Mitochondria in Signal Transduction.” The full list of papers may be found on the home page of the journal.

    View full text